Furthermore, downregulation of SIRT1 in HCC resulted in abrogation of cell proliferation and enhanced sensitivity to doxorubicin treatment by induction of senescence or apoptosis [43], [44]. The gene discussed is SIRT1; the disease is hepatocellular carcinoma.